SpringWorks Accounts Payable from 2010 to 2025

SWTX Stock  USD 54.14  0.11  0.20%   
SpringWorks Therapeutics Accounts Payable yearly trend continues to be fairly stable with very little volatility. Accounts Payable is likely to outpace its year average in 2025. Accounts Payable is the amount SpringWorks Therapeutics owes to suppliers or vendors for products or services received but not yet paid for. It represents SpringWorks Therapeutics' short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2000-03-31
Previous Quarter
9.7 M
Current Value
12.2 M
Quarterly Volatility
4.4 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check SpringWorks Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among SpringWorks Therapeutics' main balance sheet or income statement drivers, such as Interest Expense of 923.7 K, Selling General Administrative of 269.5 M or Total Revenue of 201.2 M, as well as many indicators such as Price To Sales Ratio of 13.28, Dividend Yield of 0.0 or PTB Ratio of 5.85. SpringWorks financial statements analysis is a perfect complement when working with SpringWorks Therapeutics Valuation or Volatility modules.
  
Check out the analysis of SpringWorks Therapeutics Correlation against competitors.
For more information on how to buy SpringWorks Stock please use our How to Invest in SpringWorks Therapeutics guide.

Latest SpringWorks Therapeutics' Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of SpringWorks Therapeutics over the last few years. An accounting item on the balance sheet that represents SpringWorks Therapeutics obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of SpringWorks Therapeutics are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. SpringWorks Therapeutics' Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in SpringWorks Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Slightly volatile
   Accounts Payable   
       Timeline  

SpringWorks Accounts Payable Regression Statistics

Arithmetic Mean4,222,462
Geometric Mean1,399,865
Coefficient Of Variation130.43
Mean Deviation4,532,386
Median1,350,000
Standard Deviation5,507,205
Sample Variance30.3T
Range16.6M
R-Value0.35
Mean Square Error28.4T
R-Squared0.13
Significance0.18
Slope409,328
Total Sum of Squares454.9T

SpringWorks Accounts Payable History

202512.9 M
202412.2 M
20237.4 M
2022M
20213.4 M
20201.4 M
20192.7 M

About SpringWorks Therapeutics Financial Statements

SpringWorks Therapeutics investors use historical fundamental indicators, such as SpringWorks Therapeutics' Accounts Payable, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in SpringWorks Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Accounts Payable12.2 M12.9 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for SpringWorks Stock Analysis

When running SpringWorks Therapeutics' price analysis, check to measure SpringWorks Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SpringWorks Therapeutics is operating at the current time. Most of SpringWorks Therapeutics' value examination focuses on studying past and present price action to predict the probability of SpringWorks Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SpringWorks Therapeutics' price. Additionally, you may evaluate how the addition of SpringWorks Therapeutics to your portfolios can decrease your overall portfolio volatility.